Article
Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?
- Author:
 - Anna M. Fine, PharmD
 
Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs), approved for the treatment of anemia (low red blood cells [RBCs])...
Article
Abuse-Deterrent Opioids: What Practitioners Need to Know
- Author:
 - Brenda J. Rose, PharmD
 - Anna M. Fine, PharmD
 
The meaning of the term abuse-deterrent is often misunderstood to mean abuse-proof. The FDA defines abuse-deterrent properties as those...